Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

Phase 4 Completed 12 enrolled University of Guadalajara

RandomizedCrossoverDouble-blindTreatment

Summary

Type 2 diabetes mellitus (T2DM) is characterized by wide fluctuations of glucose. The long-acting insulin has showed to improve glycemic variability however the behavior of insulin glargine versus insulin degludec is unknown.

Timeline

Start: 2013-11
Primary completion: 2015-07
Completion: 2016-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	insulin degludec	Protein / enzyme biologic	10 iu	Subcutaneous
Comparator	insulin glargine	Protein / enzyme biologic	10 iu	Subcutaneous

Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications